EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biochemical and structural analyses of metallo-β-lactamase VIM-28: impact of substitutions at residues 224 and 228 on substrate profile, stability, and zinc affinity

Hiromu Sato, Nao Ishizawa, Ryo-Ya Koto, Kaisei Hiura, Hiyori Saito, Yoshiki Kato, Nancy D Hanson, Yoshikazu Ishii iD, Akiko Shimizu-Ibuka iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.02788-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Hiromu Sato und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Life Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan. Hauptthemen laut MEDLINE: beta-Lactamases, Zinc, Pseudomonas aeruginosa, Bacterial Proteins. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metallo-β-lactamases (MBLs) hydrolyze a broad range of β-lactams, including carbapenems. VIM-28, an MBL identified in Pseudomonas aeruginosa , is an H224L/S228R variant of VIM-1 and H224L variant of VIM-4. Compared with VIM-26 (R228S), VIM-28 displayed decreased K m (12.5 for VIM-28 vs 513 μM for VIM-26; 9.66 vs 150 μM) and increased k cat / K m (15.3 vs 1.81 μM −1 s −1 ; 28.6 vs 5.89 μM −1 s −1 ) for ampicillin and cephalothin, respectively. VIM-1, which has a His in position 224 and Ser in position 228, displayed intermediate kinetic values ( K m 215 and 77.0 μM; k cat / K m 2.63 and 8.61 μM −1 s −1 ) for ampicillin and cephalothin, respectively, indicating that the presence of a positively charged residue at either position 224 or 228 enhanced substrate interactions. The combined L224H/R228S substitutions in VIM-1 increased the catalytic efficiency of the enzyme for ceftazidime by more than one order of magnitude. These kinetic trends were consistent with the minimum inhibitory concentration (MIC) data, with an eightfold increase in ceftazidime MIC for VIM-1-producing cells. Moreover, relative MIC assay showed that VIM-26 (R228S)-producing cells were more refractory to the addition of chelators than cells producing VIM-28, whereas VIM-4 (L224H)-producing cells showed reduced resistance, suggesting that the residues at positions 224 and 228 influence the metal-binding affinity of the enzyme. Differential scanning fluorimetry assay revealed that the R228S substitution increased the melting temperature of the enzyme, whereas the L224H substitution reduced its thermal stability. VIM-28 exhibited high catalytic efficiency for substrates other than ceftazidime, and the H224L substitution conferred higher zinc-binding affinity and thermal stability compared with VIM-4. IMPORTANCE β-Lactam-resistant bacteria, especially carbapenem-resistant strains, pose a major global health threat, often through metallo-β-lactamases (MBLs). To anticipate resistance evolution, we characterized VIM-28, a variant of the widespread VIM-1/VIM-4-type enzymes, focusing on the roles of two variable L10 loop residues. Substitutions at positions 224 and 228 strongly affected substrate specificity, enzyme stability, and zinc affinity. Arg228 was important for carbapenem recognition, while combined substitutions at positions 224 and 228 could enhance activity toward ceftazidime. Notably, the R228S substitution improved zinc binding and thermal stability, supporting enzyme function under zinc-limited host conditions. These findings reveal mechanisms driving MBL diversity and highlight evolutionary strategies sustaining antibiotic resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesZincPseudomonas aeruginosaBacterial ProteinsKineticsSubstrate SpecificityAnti-Bacterial AgentsAmino Acid SubstitutionThird Generation CephalosporinsEnzyme StabilityCarbapenemsAmpicillinbeta-LactamsCeftazidimeMicrobial Sensitivity Tests

Stichwörter der Autor:innen

antibiotic resistancemetallo-β-lactamaseszinc

Substanzen

beta-LactamasesZincAnti-Bacterial AgentsThird Generation CephalosporinsCarbapenemsAmpicillinbeta-LactamsBacterial ProteinsCeftazidime

Autor:innen und Institutionen

  • Department of Applied Life Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan.
  • Graduate School of Science, Kanagawa University, Yokohama, Kanagawa, Japan.
  • Department of Medical Microbiology and Immunology, Creighton University, Omaha, Nebraska, USA.
  • Department of Microbial Genomics and Ecology, Center for the Planetary Health and Innovation Science, The IDEC Institute, Hiroshima University, Higashi-Hiroshima City, Hiroshima, Japan.

ORCID-Profile: Yoshikazu Ishii, Akiko Shimizu-Ibuka

Zitieren

APA

Sato, H., Ishizawa, N., Koto, R., Hiura, K., Saito, H., Kato, Y., Hanson, N. D., Ishii, Y., & Shimizu-Ibuka, A. (2026). Biochemical and structural analyses of metallo-β-lactamase VIM-28: impact of substitutions at residues 224 and 228 on substrate profile, stability, and zinc affinity. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02788-25

Vancouver

Sato H, Ishizawa N, Koto R, Hiura K, Saito H, Kato Y, et al. Biochemical and structural analyses of metallo-β-lactamase VIM-28: impact of substitutions at residues 224 and 228 on substrate profile, stability, and zinc affinity. Microbiology Spectrum. 2026. doi:10.1128/spectrum.02788-25

BibTeX
@article{Sato2026,
  author = {Sato, Hiromu and Ishizawa, Nao and Koto, Ryo-Ya and Hiura, Kaisei and Saito, Hiyori and Kato, Yoshiki and Hanson, Nancy D and Ishii, Yoshikazu and Shimizu-Ibuka, Akiko},
  title = {Biochemical and structural analyses of metallo-β-lactamase VIM-28: impact of substitutions at residues 224 and 228 on substrate profile, stability, and zinc affinity},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.02788-25}
}
Kostenlos starten →